Psychemedics Corp financial data

Symbol
PMD on Nasdaq
Industry
Services-Medical Laboratories
Location
125 Nagog Park, Acton, MA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 149 % -9.57%
Debt-to-equity 82.6 % +8.8%
Return On Equity -69.8 % -285%
Return On Assets -38.2 % -271%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.82M shares +1.42%
Common Stock, Shares, Outstanding 5.82M shares +1.41%
Entity Public Float 22.1M USD -17.8%
Common Stock, Value, Issued 32K USD 0%
Weighted Average Number of Shares Outstanding, Basic 5.82M shares +1.8%
Weighted Average Number of Shares Outstanding, Diluted 5.74M shares +2.03%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 958K USD -22.4%
Selling and Marketing Expense 2.83M USD -9.04%
General and Administrative Expense 7.48M USD +21.2%
Operating Income (Loss) -3.44M USD -105%
Nonoperating Income (Expense) -11K USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.45M USD -57%
Income Tax Expense (Benefit) 1.11M USD +63.8%
Net Income (Loss) Attributable to Parent -4.56M USD -141%
Earnings Per Share, Basic -0.78 USD/shares -129%
Earnings Per Share, Diluted -0.68 USD/shares -94.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.43M USD -41.4%
Accounts Receivable, after Allowance for Credit Loss, Current 3.06M USD -23.6%
Assets, Current 6.01M USD -26.9%
Deferred Income Tax Assets, Net 0 USD -100%
Property, Plant and Equipment, Net 3.06M USD -33.1%
Operating Lease, Right-of-Use Asset 1.07M USD -53.7%
Other Assets, Noncurrent 531K USD -35%
Assets 10.1M USD -38.3%
Accounts Payable, Current 662K USD -17.9%
Accrued Liabilities, Current 1.84M USD -46.9%
Liabilities, Current 3.75M USD -33.5%
Deferred Income Tax Liabilities, Net 7K USD
Operating Lease, Liability, Noncurrent 623K USD -57.5%
Liabilities 4.37M USD -39.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.63M USD 0%
Retained Earnings (Accumulated Deficit) -18.3M USD -33.2%
Stockholders' Equity Attributable to Parent 5.74M USD -37.1%
Liabilities and Equity 10.1M USD -38.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -473K USD -110%
Net Cash Provided by (Used in) Financing Activities -75K USD -4.17%
Net Cash Provided by (Used in) Investing Activities 5K USD
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 6.49M shares +1.26%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -543K USD -46.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4K USD -20%
Deferred Tax Assets, Valuation Allowance 2.58M USD +188%
Deferred Tax Assets, Gross 3.52M USD +14.4%
Operating Lease, Liability 1.1M USD -56.6%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 2.07M USD -35.3%
Property, Plant and Equipment, Gross 2.51M USD -33.3%
Operating Lease, Liability, Current 464K USD -56.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 553K USD -47.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.06M USD -6.44%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 81K USD -65.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 460K USD -16.8%
Deferred Tax Assets, Operating Loss Carryforwards 87K USD +20.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 873K shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 460K USD -22.3%
Operating Lease, Payments 287K USD -1.38%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 944K USD -56.8%
Share-based Payment Arrangement, Expense 1.16M USD +49.7%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%